Medicaid Preferred Drug Lists: Cost Containment and Side Effects Alvin E. Headen Jr Introduction 07 February 2013 Pages: 1 - 3
The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003 Frank R. Lichtenberg Original Research 07 February 2013 Pages: 5 - 25
Which Physicians are Affected Most by Medicaid Preferred Drug Lists for Statins and Antihypertensives? Jonathan D. KetchamAndrew J. Epstein Original Research 07 February 2013 Pages: 27 - 40
Effects of Medicaid Access Restrictions on Statin Utilisation for Patients Treated by Physicians Practising in Poor and Minority Neighbourhoods Alvin E. Headen JrNeal A. MasiaKirsten J. Axelsen Original Research 07 February 2013 Pages: 41 - 53
Preferred Drug Lists and Medicaid Prescriptions Tamer AbdelgawadLisa Egbuonu-Davis Original Research 07 February 2013 Pages: 55 - 63
Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence David B. RidleyKirsten J. Axelsen Original Research 07 February 2013 Pages: 65 - 78
Per-patient-per-month Drug Costs in Medicare Part D Protected Classes Lisa MuchaNeal A. MasiaKirsten J. Axelsen Original Research 07 February 2013 Pages: 79 - 84
